Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diabetes Will's Way is a U.S.-based nonprofit focused on reducing the financial burden of Type 1 diabetes care for children, young adults, and families who are underinsured. Rather than developing therapeutics, the organization provides direct financial assistance for essential diabetes supplies and diabetes-related costs, including insulin, glucagon, pumps, continuous glucose monitors, hospital bills, and other urgent needs. Its grant programs include support for durable medical equipment and emergency expenses, with a national scope across multiple states. Founded by Will Oberndorfer and Lisa Oberndorfer, the organization operates as a patient-support and advocacy-focused healthcare nonprofit rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diabetes Will's Way.